Industry Insights
-
Latest CISCRP Patient Survey Reveals Diversity Gaps, Yields 5 Tips For Improvement
3/20/2024
Results from the latest CISCRP “Perceptions & Insights” study reveal five opportunities to improve clinical trial recruitment and participation, especially among ethnic and racial minority groups.
-
How Different Are Oncology Clinical Trials?
3/19/2024
Oncology clinical trials pose unique challenges. Dive into five key reasons behind the intricacies of oncology trials, from recruitment hurdles to data volume and efficacy endpoints.
-
The Workhorse Of Today’s Clinical Trials
3/19/2024
Unlock the power of decentralized clinical trials with an electronic data capture platform (EDC). Discover how stakeholders benefit and what to consider when choosing the right EDC system.
-
Supporting NASH/NAFLD's Unmet Needs With ePRO
3/19/2024
Explore the rising prevalence of NASH/MASH, its debilitating effects, and the urgent need for patient-centric approaches in clinical research.
-
Why Small Clinical-Stage Companies Need Developmental Risk Management Plans
3/19/2024
For small clinical-stage companies, developmental risk management plans are not a regulatory requirement but a strategic imperative to proactively manage risks.
-
Why The ‘Illusion’ Of Speed In Clinical Trials Unravels As Contracting Demands Scale
3/19/2024
Discover four mistakes biotechs often make in haste (and how to avoid them) as they hurry through clinical trial contracting on the path to commercilization.
-
Informed Consent In Clinical Trials: Understanding The FDA’s And OHRP’s Joint Draft Guidance
3/18/2024
The FDA and OHRP have jointly issued a new draft guidance about how sponsors, investigators, and IRBs should structure and present informed consent documents to clinical research participants.
-
What’s Needed To Keep Tinnitus Research From Going Quiet
3/18/2024
Finding effective treatments for tinnitus has often been circuitous and frustrating for many patients. Tinnitus expert Marc Fagelson, Ph.D., explores the current treatment landscape and what can be done to improve outcomes for patients.
-
Blend ERP With Netsuite For Process Manufacturing Efficiency
3/15/2024
Life sciences companies face myriad challenges, from regulatory hurdles to complex supply chains. See how Blend ERP tackles these obstacles, driving efficiency and innovation.
-
Handling Substantial Modifications Under The CTR
3/15/2024
The transition of ongoing clinical trials to meet CTR requirements can be challenging. Examine some key considerations, including substantial modification processes and strategic dossier updates.